Enjoying dipping into your newsletter. Good origin stories. Are you aware of how French/German (to some extent UK) patent laws drove the Novartis-Ciba-Geigy and the Hoffman-Roche groups to Basel and that’s a part reason for the Swiss pharma strength today ??
Also, in terms of future - seems like a win for the CROs. AI to discover it but you still need CROs to develop them and trial esp. if you don’t have large pharma infrastructure.
Enjoying dipping into your newsletter. Good origin stories. Are you aware of how French/German (to some extent UK) patent laws drove the Novartis-Ciba-Geigy and the Hoffman-Roche groups to Basel and that’s a part reason for the Swiss pharma strength today ??
Also, in terms of future - seems like a win for the CROs. AI to discover it but you still need CROs to develop them and trial esp. if you don’t have large pharma infrastructure.
I had the good fortune to work with Deerfield at my last job. Those guys are not messing around